MeiraGTx Holdings (MGTX) Other Non Operating Income (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Other Non Operating Income of -$8.6 million for Q4 2025, down 55.64% on a YoY basis from -$19.4 million in Q4 2024, and down 452.44% quarter-over-quarter from -$1.6 million in Q3 2025.
MeiraGTx Holdings (MGTX) Other Non Operating Income (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Other Non Operating Income for 9 years, with the latest figure at -$8.6 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non Operating Income fell 55.64% year-over-year to -$8.6 million; the trailing twelve-month figure through Dec 2025 stood at $2.1 million (up 174.36% YoY), and the FY2025 full-year result was $2.1 million, up 174.36% from the prior year.
- Other Non Operating Income for Q4 2025 stood at -$8.6 million, down from -$1.6 million in the prior quarter.
- The five-year high for Other Non Operating Income was $26.3 million in Q4 2022, with the low at -$12.8 million in Q3 2022.
- Historically, Other Non Operating Income has averaged -$400200.0 across 5 years, with a median of -$409500.0 in 2024.
- Annual changes were most pronounced in 2024 — Other Non Operating Income plunged 28300.0% — and 2025, when it soared 3136.62%.
- MeiraGTx Holdings' Other Non Operating Income stood at -$1.7 million in 2021, then surged by 1651.8% to $26.3 million in 2022, then tumbled by 98.3% to $446000.0 in 2023, then plunged by 1339.91% to -$5.5 million in 2024, then sank by 55.64% to -$8.6 million in 2025.
- The last three Other Non Operating Income figures came in at -$8.6 million (Q4 2025), -$1.6 million (Q3 2025), and $8.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.61 Mn |
| Sep 30, 2025 | -1.56 Mn |
| Jun 30, 2025 | 8.62 Mn |
| Mar 31, 2025 | 3.69 Mn |
| Dec 31, 2024 | -5.53 Mn |
| Sep 30, 2024 | 3.46 Mn |
| Jun 30, 2024 | -284,000.00 |
| Mar 31, 2024 | -535,000.00 |
| Dec 31, 2023 | 446,000.00 |
| Sep 30, 2023 | -8.68 Mn |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | 3.86 Mn |
| Dec 31, 2022 | 26.27 Mn |
| Sep 30, 2022 | -12.84 Mn |
| Jun 30, 2022 | -10.43 Mn |
| Mar 31, 2022 | 397,000.00 |
| Dec 31, 2021 | -1.69 Mn |
| Sep 30, 2021 | -3.37 Mn |
| Jun 30, 2021 | 381,000.00 |
| Mar 31, 2021 | -1.62 Mn |